The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThalassa (di) Regulatory News (THAL)

Share Price Information for Thalassa (di) (THAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 24.00
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 2.00 (8.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 25.00
THAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Mar 2020 07:00

RNS Number : 5630E
Thalassa Holdings Limited
02 March 2020
 

Thalassa Holdings Ltd

(Reuters: THAL.L, Bloomberg: THAL:LN)

Trading update

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

Given the current volatility in world stock markets brought on in large part by the Coronavirus outbreak, the board of Thalassa Holdings Ltd ("THAL" or "the Company") wishes to update the market on Group trading ahead of the release of its financial results for the year ended 31 December by 31 March 2020.

 

Thalassa

·; The Group was well positioned going into this period of market volatility through being both long in cash and hedged through a combination of different strategies that provide unlimited upside but limited downside. These strategies include short currency positions, long and short/inverse ETFs against our long holdings. The board would emphasise that these hedges can only partially offset the impact on long holdings of a prolonged major market correction as the Group is set up as a net long buyer of undervalued assets.

·; Thalassa currently has net cash balances of ca. $10.1 million and ca. $5.9 million invested in Miscellaneous Holdings (as further iterated below and which do not include Core Holdings) and hedges.

·; Thalassa's investments in various companies total $3.3 million and hedge positions, excluding currency hedges, total $2.6 million.

 

Miscellaneous Holdings

·; Thalassa holds a number of undisclosed positions in listed companies which the board believes are undervalued. Our policy to not disclose the identity of these holdings, unless required for compliance purposes as in the case of Newmark Securities (NWT LN) where we have a disclosed holding of 9.04%, is solely down to the often illiquid nature of the shares of the companies we are dealing in.

·; In the year to date, Thalassa has realised gains of ca. $570,000 from the disposal of long positions and hedges and has, as at the time of writing, ca. $464,000 of net unrealised gains of which ca. $400,000 are on hedge positions, $10,000 on currency hedges and the balance of ca. $54,000 on long positions.

 

Core Holdings

Anemoi S.A.

·; Anemoi has been set up as a Special Purpose Acquisition Company (SPAC) with the intention of acquiring a significant operating company, which the board believes to be undervalued and which offers significant potential capital upside. The Company is currently seeking a listing of Anemoi on the Luxembourg Stock Exchange.

 

Apeiron Holdings AG

·; As previously announced, Apeiron has successfully completed the acquisition of id4 AG, which is working hard to secure contracts for its RegTech software and recently announced a technological partnership with the leading Swiss pension platform lemania pension hub to provide id4's client lifecycle management software.

 

Autonomous Robotics Limited ("ARL")

·; As previously announced, proof of concept has been achieved and management is now, in addition to continued product development, largely focused on securing commercial and/or defence partnership(s) in order to commercialise the company's undersea autonomous nodes. [Exploratory discussions with potential partners are ongoing, although there can be no certainty that these will lead to an agreement].

 

The Local Shopping REIT Plc ("LSR")

·; The board regrets that it is unable to comment outside of announcements made by LSR. Information on LSR can be found under the ticker (LSR LN) and Thalassa currently holds 92.6% of LSR's issued share capital.

 

Gitone Beteiligungsverwaltungs GmbH ("Gitone")

·; As previously announced, Thalassa has entered into an €11 million convertible loan agreement with Gitone Beteiligungsverwaltungs GmbH, Austria. The underlying asset in which Thalassa currently has an indirect interest in is Liburnia Riviera Hotels (LRH ZA) (www.liburnia.hr).

·; Clearly the Coronavirus outbreak is a concern to everyone in the Travel and Leisure industry and the board is monitoring the situation carefully.

 

Duncan Soukup, Chairman of THAL stated:

"The board of Thalassa has, since the sale of WGP in January 2018, undertaken a number of initiatives which, unsurprisingly, have taken longer to develop than we would have liked.

"M&A transactions invariably take considerably longer to develop and execute than instantaneous dealings in the stock market. However, Thalassa's board is convinced that the best way to generate substantial returns for shareholders is through long term investing and the acquisition of undervalued assets. In the past two years global stock markets have raced ahead, with numerous story stocks such as Tesla and Virgin Galactic Holdings (SPCE US), defying gravity, at least until a few of days ago. At its recent high, SPCE US sported a very healthy market capitalisation of ca. $8.3 billion (20 Feb 2020) but is now down, at the time of writing, to $4.8 billion and looking like it is going lower. Still not bad for a company with no revenues, much less any earnings!

 

"As a value investor the past two years have, on the one hand, been somewhat frustrating due to difficulty in closing some transactions but they have also reminded us that patience is ultimately rewarded. The Company has succeeded in buying back ca. 35% of its outstanding shares at a significant discount to the book value (BV) and the board believes the Company is now well-positioned to take advantage of the current global stock market correction, which we believe is far from over."

"We believe that the Coronavirus outbreak behoves comment; your board is convinced that Politics and Medicine are the worst of bedfellows and that the World Health Organisation ("WHO") leadership is woefully understating the implications and severity of the Coronavirus outbreak. Given that the only certainty of the Coronavirus is that the world does not know exactly what it is, where it came from or how to treat it, one doesn't have to be a rocket scientist to suggest that the world should prepare for the worst and hope for the best rather than just hoping it will miraculously disappear.

"Europe's decision to keep borders open, notwithstanding the spread of the virus, is clearly understandable from both a political and economic perspective but appears, even to the uneducated layman, to fly in the face of the belated action taken by the Chinese government to ring fence Hubei Province. Clearly the powers that be are fixated on their rear-view mirrors and will not take action until significant damage has been done. Plus ca change!"

"We do not envy any government the decision as to how to respond to a major health crisis. However, if history teaches us anything, the world was slow to react to both the SARS and Ebola outbreaks and history will probably repeat itself with the current Coronavirus outbreak. Between 2002 and 2003 there were 8,098 cases of SARS virus and 774 deaths in 17 countries whilst the 1976/ongoing deadly Ebola virus, which is still prevalent in Africa and which has so far killed over 11,323 people! In July 2019 the WHO declared the Congo Ebola outbreak a world health emergency (source: Wikipedia)."

"To date there have been 82,585 Coronavirus cases reported and 2,814 deaths…(source: www.worldometers.info/coronavirus/).

"If the above statistics are any precursor to the future…it does not bode well for rapid containment of the Coronavirus, nor for the stock market; as a result, we will maintain our hedge positions, continue to develop our core holdings…and prepare for the worst whilst hoping for the best."

"To quote Winston Churchill, "Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning."

 

END

Enquiries:

Thalassa Holdings Ltd

Duncan Soukup (Executive Chairman)

+33 (0)6 78 63 26 89

WH Ireland Limited (Financial Adviser)

+44 (0)207 220 1650

Chris Fielding, Managing Director, Corporate Finance

 

www.thalassaholdingsltd.com

Note to Editors:

About Thalassa

Thalassa Holdings Ltd, incorporated and registered in the BVI, is a holding company with various interests across a number of industries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUWUNRRWUUUAR
Date   Source Headline
30th Apr 20243:40 pmEQSThalassa Holdings Ltd:
30th Apr 20243:33 pmEQSThalassa Holdings Ltd: Annual Financial Report
12th Jan 20247:36 amEQSThalassa Holdings Ltd: Trading Update
16th Nov 202312:27 pmEQSThalassa Holdings Ltd: TR1
29th Sep 20239:01 amEQSThalassa Holdings Ltd: Interim Results (30 June 2023)
28th Sep 202311:09 pmEQSThalassa Holdings Ltd: Amendment to Articles of Association
17th Jul 20238:12 amEQSThalassa Holdings Ltd: Restoration of Listing
10th Jul 202310:50 amEQSThalassa Holdings Ltd: Final Results For Year Ended 31 December 2022
30th Jun 20237:57 pmEQSThalassa Holdings Ltd: Result of AGM
7th Jun 20237:51 pmEQSThalassa Holdings Ltd: AGM Proxy Form
5th Jun 202311:20 amEQSThalassa Holdings Ltd: Notice of AGM
2nd May 20237:51 amEQSThalassa Holdings Ltd: Temporary Suspension
2nd May 20237:30 amRNSSuspension - Thalassa Holdings Ltd
19th Apr 20238:45 pmEQSAppointment of Auditor
14th Feb 20234:12 pmEQSThalassa Holdings Ltd: Confirmation of previously announced proposal
27th Jan 20233:40 pmEQSThalassa Holdings Ltd: Trading Statement
27th Jan 20232:40 pmEQSThalassa Holdings Ltd: Trading Statement
13th Dec 20227:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
13th Dec 20226:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
24th Oct 20228:35 amEQSThalassa Holdings Ltd: Correction
24th Oct 20228:34 amEQSThalassa Holdings Ltd: Correction
21st Oct 202211:00 amEQSThalassa Holdings Ltd: Directorate Change
21st Oct 202210:59 amEQSThalassa Holdings Ltd: Directorate Change
15th Aug 20227:01 amEQSThalassa Holdings Ltd: Interim Results
15th Aug 20227:00 amEQSThalassa Holdings Ltd: Interim Results
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
27th Jun 20221:03 pmEQSThalassa Holdings Ltd: Appointment of Broker
27th Jun 20221:02 pmEQSThalassa Holdings Ltd: Appointment of Broker
9th Jun 20223:37 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:34 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:19 pmEQSThalassa Holdings Ltd: Notice of AGM
9th Jun 20223:18 pmEQSThalassa Holdings Ltd: Notice of AGM
24th May 202211:27 amEQSThalassa Holdings Ltd: Appointment of Non-Executive Director
28th Feb 20221:37 pmEQSThalassa Holdings Ltd: Trading Statement
17th Dec 20217:17 amRNSReverse Takeover of id4 AG by Anemoi International
15th Nov 20219:01 amRNSid4 delivers Client Space solution
28th Oct 20215:00 pmRNSHolding(s) in Company
7th Oct 20213:59 pmRNSResult of AGM
28th Sep 20217:00 amRNSInterim Results
17th Sep 202112:50 pmRNSLondon Medical Laboratory investment update
30th Jul 20213:23 pmRNSProposed Transaction
22nd Jun 202110:29 amRNSFinal Results for YE 31 Dec 2020 and Notice of AGM
14th Jun 20217:00 amRNSPreliminary Results for the year ended 31 Dec 20
29th Apr 20217:01 amRNSGrant Funded Project for Autonomous Robotics Ltd
29th Apr 20217:00 amRNSNotice of Results
8th Mar 20217:00 amRNSDe-listing from Luxembourg Stock Exchange
3rd Mar 20217:00 amRNSAppointment of Chief Financial Officer
4th Feb 202111:17 amRNSThalassa subsidiary id4 wins at Swiss WB Awards
2nd Feb 20217:00 amRNSInvestment in London Medical Laboratory Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.